FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Track all the latest updates and news of Claris IPO.
November 19, 2024 8:30:00 PM
Aclaris Therapeutics has secured an exclusive licence from Biosion for the global rights to two new antibodies, BSI-045B and BSI-502, excluding Greater China. Biosion will be eligible for a $40m ...
Published by : GlobalData on MSNIPO Listing Detail
Listing Date: Monday, December 20, 2010
BSE Scrip Code: 533288
Listing In: 'B' Group of Securities
ISIN: INE562G01018
Issue Price: Rs. 228.00 Per Equity Share
Face Value: Rs. 10.00 Per Equity Share
Claris Lifesciences Ltd IPO allotment status is now available online.
Claris Lifesciences IPO was open on Nov 24, 2010 and closed on Dec 02, 2010. IPO of Claris was oversubscribed by 1.50 times (1.60 times in retail).
Claris Lifesciences Ltd (CLL) IPO finally subscribed 1.50 times on its closing day. Claris IPO was open on Nov 24, 2010 and closed today on Dec 02, 2010 for subscription.
Oversubscription detail
Qualified Institutional Buyers (QIBs): 1.31 Times
Non Institutional Investors: 2.03 Times
Retail Individual Investors (RIIs): 1.60 Times
Total: 1.50 Times
Alert:
Book Running Lead Manager to the issue has informed the Exchange that the CLARIS LIFESCIENCES LIMITED issue will close on 2 Dec, 2010 instead of the earlier closing day on 26 Nov, 2010.Post issue modification date has been revised to 3 Dec, 2010 instead of the earlier closing day on 27 Nov, 2010. Further price band has revised from 278/- to Rs. 293/- TO Rs. 228/- to Rs. 235/- per share
Claris Lifesciences Limited (CLL) is entering in the capital markets with an initial public offering, IPO of Rs. 300.00 Crore. The price band for the issue has been fixed at Rs 278/- at lower level and Rs 293/- at upper level.
Incorporated in 1994, Claris Lifesciences Limited (CLL) is an Ahmedabad based pharmaceutical company. Claris is the largest Indian sterile injectables pharmaceutical companies with a presence in 76 countries worldwide. Claris offers 113 products across multiple markets and therapeutic areas. All of these products are off-patent products.
The issue opens on Nov 24, 2010, and closes for subscription on Nov 26, 2010. The equity shares of the issue are proposed to be listed on the Bombay Stock Exchange (BSE).
The Claris IPO is proposed to open on November 24, 2010. The IPO application ends on December 2, 2010.
Retail investors can apply in the retail or non-institutional investor category from November 24, 2010 to December 2, 2010. The Claris IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Claris IPO will open for subscription on November 24, 2010. The public issue will close on December 2, 2010.
Useful Articles
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|